Samuel Rae
Contributor since: 2013
Latest Articles
Vuzix Could Leverage Its Early Strength To Establish A Leadership Position In Augmented Reality
22nd Century Group Is Down But Could Quickly Recover
VBI Vaccines Might Be A Recovery Play After A Dip
These 2 Payment Processors Could Be Next In Line For Acquisition
Commercial Augmented Reality Is Where Vuzix Should Reward Shareholders
These Two Biotech Stocks Could Move On Near Term Vaccine Catalysts
3 Companies With Three Different Approaches To Immuno-Oncology
Here's Why Wirecard AG Makes For An Attractive Exposure To Growth In The Payments Processing Space
Why Alder Biopharmaceuticals Is Down - And What To Do About It
3 Companies With Near-Term Catalysts In The Hepatitis B Space
Getting To The Details At 22nd Century Group, Inc.
VBI Vaccines Is An Alternative To The Agenus Inc. Failure
Here's Where Oramed Fits Into The Diabetes Space
VBI Vaccines Is In Line For Investment Reallocation Boost From Novavax's Failure In RSV
Diabetes Patients Need Earlier Administration Insulin: Novo Nordisk And Oramed Take The Lead
Insys Therapeutics Is Hoping Syndros Is Its Blockbuster Marijuana Ticket
Here's Why Twitter Is Worthless As An Investment
Chiasma: An All Or Nothing Play
This Phase II Liver Cancer Data Could Boost Arbutus Going Forward
Here's Why GW Pharmaceuticals Shareholders Could Be In For A Big Month
Depression Target Aside, Alkermes Still Has Two Blockbuster Therapies In Its Pipeline
How Pershing Compares To Barrick's Bundle Of For-Sales
The Long And Short Of Twitter
Record Financials Highlight IZEA's Foothold In The Native Advertising Space
Updated Technical Report Puts Pershing On Track Heading Into 2015
Here's Why The Time Is Right To Invest In Pershing Gold
Altria Group's April 24, 2014 Earnings Report
How To Invest In Bitcoin Without Buying Bitcoin
3 Very Different Exposures To The Marijuana Industry
How Brazilian Resources' Strategy Translates To Upside Potential
Kingold Jewelry Is Fundamentally Undervalued, But Not For Long
4 Reasons Why MGT Capital Is Dramatically Undervalued